These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8225679

  • 1. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME, Richer S, Berk MA, Mosnaim AD.
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [Abstract] [Full Text] [Related]

  • 2. Ocular complications of chlorpromazine therapy.
    Petrohelos MA, Tricoulis D.
    Ophthalmologica; 1969 Aug; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract] [Full Text] [Related]

  • 3. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS, Prado R, Pederson JF, Dunnick CA, Lucas LM.
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [Abstract] [Full Text] [Related]

  • 4. Ocular complications of phenothiazines.
    Mathalone MB.
    Trans Ophthalmol Soc U K (1962); 1966 May; 86():77-88. PubMed ID: 5226613
    [No Abstract] [Full Text] [Related]

  • 5. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
    Thaler JS, Curinga R, Kiracofe G.
    Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962
    [Abstract] [Full Text] [Related]

  • 6. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine].
    Baron JB, Morel P, Rivoallan Y, Soulairac A.
    Agressologie; 1968 Sep; 9(2):293-304. PubMed ID: 5675496
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
    Francesconi G, Di Tizio A, Cameo D.
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
    [No Abstract] [Full Text] [Related]

  • 9. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB.
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Synthetic antimalarials and skin].
    Ribrioux A.
    Ann Dermatol Venereol; 1990 Mar; 117(12):975-90. PubMed ID: 2150584
    [No Abstract] [Full Text] [Related]

  • 12. An electron microscopic study of chlorpromazine pigmentation.
    Hashimoto K, Wiener W, Albert J, Nelson RG.
    J Invest Dermatol; 1966 Oct; 47(4):296-306. PubMed ID: 5954160
    [No Abstract] [Full Text] [Related]

  • 13. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Oct; 69(6):935-9. PubMed ID: 4905472
    [No Abstract] [Full Text] [Related]

  • 14. Ocular complications related to phenothiazines.
    Siddall JR.
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
    [No Abstract] [Full Text] [Related]

  • 15. Unusual complications of antipsychotic drugs.
    Diamond JM, Santos AB.
    Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024
    [Abstract] [Full Text] [Related]

  • 16. Ocular complications of chlorpromazine therapy.
    Petrohelos MA, Tricoulis D.
    Ophthalmologica; 1969 Oct; 159(1):31-8. PubMed ID: 4984273
    [No Abstract] [Full Text] [Related]

  • 17. [Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants].
    Panzitt M, Simon M, Weger M.
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):273-5. PubMed ID: 11392274
    [Abstract] [Full Text] [Related]

  • 18. Blue skin pigmentation and chlorpromazine.
    Haddad RI.
    J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129
    [No Abstract] [Full Text] [Related]

  • 19. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ, Bowerman L, Thompson LR.
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [Abstract] [Full Text] [Related]

  • 20. [Ophthalmologic study of patients receiving psychotropic drugs].
    Gol'dovskaia IL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.